Back to the main directory
company_researchgreater_china / Equity
- Industrial and Commercial Bank of China (1398 HK) : 1H20: Results below expectations. Stable growth on retail lending. by UOB
- Yangtze Optical Fibre And Cable (6869 HK) : 2Q20: Earnings and margins rebound sequentially. by UOB
- BAIC Motor (1958 HK): 2Q20 : Net profit up 15% yoy, beating estimates. BUY by UOB
- China Zhengtong Auto Services (1728 HK) : 1H20: Unexpected loss, cut target price to HK$0.55. SELL by UOB
- China Oriental Group Co Ltd (581 HK) : 1H20: Net profit declined by 53.5% yoy on sales volume drop and margin squeeze. by UOB
- Baoshan Iron & Steel (600019 CH) : 1H20: Results beat expectation; stay clam amid headwinds. by UOB
- Shandong Fengxiang (9977 HK) : 1H20: Core businesses in-line, drag comes from chicken breeding. by UOB
- Trip.com Group (TCOM US) : 2Q20: Recovery pace well on track, 3Q20 bottom-line guided to turn black. by UOB
- New Oriental Education & Technology Group (EDU US) : 1QFY21: Sequential recovery to accelerate until 2HFY21. by UOB
- TAL Education Group (TAL US) : 2QFY21: Earnings miss on higher marketing spend, 3QFY21 revenue guidance below expectation. by UOB
- Sinopharm Group (1099 HK) : 9M20: Earnings Up By 7.90% yoy, Stronger Than Expected; Upgrade To HOLD. by UOB
- Kweichow Moutai (600519 CH) : 3Q20: No Concerns About The Modest Results. by UOB
- Ping An Good Doctor (1833 HK) : Dedicated online healthcare services provider. by UOB
- Contemporary Amperex Technology Co (300750 CH): 3Q20 - Net profit up 4% yoy and 19% qoq, in line. BUY by UOB
- ZTE Corporation (763 HK) : 3Q20: Net profit declines 68% yoy, Missing expectations by UOB
- Hangzhou Robam Appliances (002508 CH) : 3Q20: Rebound in sales and margins; Upgrade to HOLD. by UOB
- Shanxi Xinghuacun Fenjiu (600809 CH) : 3Q20: Acceleration in development of outside Shanxi markets. by UOB
- Sany Heavy Industry (600031 CH) : 3Q20: Solid earnings, beating estimates. by UOB
- Fuyao Glass Industry Group (3606 HK) : 3Q20: Results beat estimates, Raise target price to HK$39.00, Upgrade to BUY. by UOB
- Shenzhen Mindray Bio-Medical Electronics (300760 CH) : 9M20: Net profit up 46.1% yoy, China operations will be new growth driver. by UOB
- WuXi AppTec (2359 HK) : 9M20: Adjusted earnings growth accelerated at higher-than-expected 34.5% yoy. by UOB
- Yangtze Optical Fibre and Cable (6869 HK) : 3Q20 - Missed on operating expense hikes. HOLD by UOB
- China Merchants Bank (3968 HK) : 3Q20: Strong NIM expansion was a key differentiating factor. by UOB
- China Shineway Pharmaceutical (2877 HK) : 3Q20: Revenue increased by 1.1% yoy, TCM formula granule business leads the recovery. by UOB
- Link REIT (823 HK) : 1HFY21: Within expectations; Expect earnings recovery on easing of social distancing measures. by UOB